Cargando…

Gene Expression in Uninvolved Oral Mucosa of OSCC Patients Facilitates Identification of Markers Predictive of OSCC Outcomes

Oral and oropharyngeal squamous cell carcinomas (OSCC) are among the most common cancers worldwide, with approximately 60% 5-yr survival rate. To identify potential markers for disease progression, we used Affymetrix U133 plus 2.0 arrays to examine the gene expression profiles of 167 primary tumor s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lohavanichbutr, Pawadee, Houck, John, Doody, David R., Wang, Pei, Mendez, Eduardo, Futran, Neal, Upton, Melissa P., Holsinger, F. Christopher, Schwartz, Stephen M., Chen, Chu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460916/
https://www.ncbi.nlm.nih.gov/pubmed/23029552
http://dx.doi.org/10.1371/journal.pone.0046575
_version_ 1782245012696727552
author Lohavanichbutr, Pawadee
Houck, John
Doody, David R.
Wang, Pei
Mendez, Eduardo
Futran, Neal
Upton, Melissa P.
Holsinger, F. Christopher
Schwartz, Stephen M.
Chen, Chu
author_facet Lohavanichbutr, Pawadee
Houck, John
Doody, David R.
Wang, Pei
Mendez, Eduardo
Futran, Neal
Upton, Melissa P.
Holsinger, F. Christopher
Schwartz, Stephen M.
Chen, Chu
author_sort Lohavanichbutr, Pawadee
collection PubMed
description Oral and oropharyngeal squamous cell carcinomas (OSCC) are among the most common cancers worldwide, with approximately 60% 5-yr survival rate. To identify potential markers for disease progression, we used Affymetrix U133 plus 2.0 arrays to examine the gene expression profiles of 167 primary tumor samples from OSCC patients, 58 uninvolved oral mucosae from OSCC patients and 45 normal oral mucosae from patients without oral cancer, all enrolled at one of the three University of Washington-affiliated medical centers between 2003 to 2008. We found 2,596 probe sets differentially expressed between 167 tumor samples and 45 normal samples. Among 2,596 probe sets, 71 were significantly and consistently up- or down-regulated in the comparison between normal samples and uninvolved oral samples and between uninvolved oral samples and tumor samples. Cox regression analyses showed that 20 of the 71 probe sets were significantly associated with progression-free survival. The risk score for each patient was calculated from coefficients of a Cox model incorporating these 20 probe sets. The hazard ratio (HR) associated with each unit change in the risk score adjusting for age, gender, tumor stage, and high-risk HPV status was 2.7 (95% CI: 2.0–3.8, p = 8.8E-10). The risk scores in an independent dataset of 74 OSCC patients from the MD Anderson Cancer Center was also significantly associated with progression-free survival independent of age, gender, and tumor stage (HR 1.6, 95% CI: 1.1–2.2, p = 0.008). Gene Set Enrichment Analysis showed that the most prominent biological pathway represented by the 71 probe sets was the Integrin cell surface interactions pathway. In conclusion, we identified 71 probe sets in which dysregulation occurred in both uninvolved oral mucosal and cancer samples. Dysregulation of 20 of the 71 probe sets was associated with progression-free survival and was validated in an independent dataset.
format Online
Article
Text
id pubmed-3460916
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34609162012-10-01 Gene Expression in Uninvolved Oral Mucosa of OSCC Patients Facilitates Identification of Markers Predictive of OSCC Outcomes Lohavanichbutr, Pawadee Houck, John Doody, David R. Wang, Pei Mendez, Eduardo Futran, Neal Upton, Melissa P. Holsinger, F. Christopher Schwartz, Stephen M. Chen, Chu PLoS One Research Article Oral and oropharyngeal squamous cell carcinomas (OSCC) are among the most common cancers worldwide, with approximately 60% 5-yr survival rate. To identify potential markers for disease progression, we used Affymetrix U133 plus 2.0 arrays to examine the gene expression profiles of 167 primary tumor samples from OSCC patients, 58 uninvolved oral mucosae from OSCC patients and 45 normal oral mucosae from patients without oral cancer, all enrolled at one of the three University of Washington-affiliated medical centers between 2003 to 2008. We found 2,596 probe sets differentially expressed between 167 tumor samples and 45 normal samples. Among 2,596 probe sets, 71 were significantly and consistently up- or down-regulated in the comparison between normal samples and uninvolved oral samples and between uninvolved oral samples and tumor samples. Cox regression analyses showed that 20 of the 71 probe sets were significantly associated with progression-free survival. The risk score for each patient was calculated from coefficients of a Cox model incorporating these 20 probe sets. The hazard ratio (HR) associated with each unit change in the risk score adjusting for age, gender, tumor stage, and high-risk HPV status was 2.7 (95% CI: 2.0–3.8, p = 8.8E-10). The risk scores in an independent dataset of 74 OSCC patients from the MD Anderson Cancer Center was also significantly associated with progression-free survival independent of age, gender, and tumor stage (HR 1.6, 95% CI: 1.1–2.2, p = 0.008). Gene Set Enrichment Analysis showed that the most prominent biological pathway represented by the 71 probe sets was the Integrin cell surface interactions pathway. In conclusion, we identified 71 probe sets in which dysregulation occurred in both uninvolved oral mucosal and cancer samples. Dysregulation of 20 of the 71 probe sets was associated with progression-free survival and was validated in an independent dataset. Public Library of Science 2012-09-28 /pmc/articles/PMC3460916/ /pubmed/23029552 http://dx.doi.org/10.1371/journal.pone.0046575 Text en © 2012 Lohavanichbutr et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Lohavanichbutr, Pawadee
Houck, John
Doody, David R.
Wang, Pei
Mendez, Eduardo
Futran, Neal
Upton, Melissa P.
Holsinger, F. Christopher
Schwartz, Stephen M.
Chen, Chu
Gene Expression in Uninvolved Oral Mucosa of OSCC Patients Facilitates Identification of Markers Predictive of OSCC Outcomes
title Gene Expression in Uninvolved Oral Mucosa of OSCC Patients Facilitates Identification of Markers Predictive of OSCC Outcomes
title_full Gene Expression in Uninvolved Oral Mucosa of OSCC Patients Facilitates Identification of Markers Predictive of OSCC Outcomes
title_fullStr Gene Expression in Uninvolved Oral Mucosa of OSCC Patients Facilitates Identification of Markers Predictive of OSCC Outcomes
title_full_unstemmed Gene Expression in Uninvolved Oral Mucosa of OSCC Patients Facilitates Identification of Markers Predictive of OSCC Outcomes
title_short Gene Expression in Uninvolved Oral Mucosa of OSCC Patients Facilitates Identification of Markers Predictive of OSCC Outcomes
title_sort gene expression in uninvolved oral mucosa of oscc patients facilitates identification of markers predictive of oscc outcomes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460916/
https://www.ncbi.nlm.nih.gov/pubmed/23029552
http://dx.doi.org/10.1371/journal.pone.0046575
work_keys_str_mv AT lohavanichbutrpawadee geneexpressioninuninvolvedoralmucosaofosccpatientsfacilitatesidentificationofmarkerspredictiveofosccoutcomes
AT houckjohn geneexpressioninuninvolvedoralmucosaofosccpatientsfacilitatesidentificationofmarkerspredictiveofosccoutcomes
AT doodydavidr geneexpressioninuninvolvedoralmucosaofosccpatientsfacilitatesidentificationofmarkerspredictiveofosccoutcomes
AT wangpei geneexpressioninuninvolvedoralmucosaofosccpatientsfacilitatesidentificationofmarkerspredictiveofosccoutcomes
AT mendezeduardo geneexpressioninuninvolvedoralmucosaofosccpatientsfacilitatesidentificationofmarkerspredictiveofosccoutcomes
AT futranneal geneexpressioninuninvolvedoralmucosaofosccpatientsfacilitatesidentificationofmarkerspredictiveofosccoutcomes
AT uptonmelissap geneexpressioninuninvolvedoralmucosaofosccpatientsfacilitatesidentificationofmarkerspredictiveofosccoutcomes
AT holsingerfchristopher geneexpressioninuninvolvedoralmucosaofosccpatientsfacilitatesidentificationofmarkerspredictiveofosccoutcomes
AT schwartzstephenm geneexpressioninuninvolvedoralmucosaofosccpatientsfacilitatesidentificationofmarkerspredictiveofosccoutcomes
AT chenchu geneexpressioninuninvolvedoralmucosaofosccpatientsfacilitatesidentificationofmarkerspredictiveofosccoutcomes